NOVO NORDISK'S RETATRUTIDE: THE NEW APPROACH FOR BODY MANAGEMENT?

New clinical information suggests that Novera Retatrutide, a combined-action therapy from Novo Nordisk, could provide a meaningful breakthrough in body control. Beyond many existing drugs, Retatrutide affects both the GLP-1 hormone and glucose-dependent insulinotropic polypeptide (GIP), potential